Xrf Scientific Limited · ASX:XRF
Xrf Scientific — Investor Presentation (August 2021)
17 slides from Xrf Scientific's investor presentation, Aug 24, 2021
Slide 1: Investor Presentation August 2021
Investor Presentation August 2021
Slide 2: Our Technology
Our Technology Sample Preparation Technology Mining and Manufacturing Chemical Analysis Raw Prepared Samples Samples Minerals: Materials: Iron ore Cement Analysis Techniques: Nickel Steel XRF Copper Glass ICP Aluminium Ceramics Bauxite Research Manganese Education Uranium Lithium Mineral sands Comme
Slide 3: Lab Products: Sample Preparation Products
Lab Products Sample Preparation Products Platinum Labware X-Ray Flux Recycling service of turning used platinum products into new items Fusion Machines 3
Slide 4: Lab Products: Analytical Tools and Accessories
Lab Products Analytical Tools and Accessories Weighing Instruments Platinum Electrodes Drift Monitors 4
Slide 5: Platinum Products
Platinum Products Precision Products for Industry Aerospace Glass Production Crystal Growing Measurement Components Bushings Vessels Instrument Components Chemical Laboratory Research and Niche Applications / Production Components Development Custom Designs Vessels 5
Slide 6: FY21 Highlights
FY21 Highlights Record revenue and profit All divisions profitable and growing Very strong demand from mining and industrial customers – driven by commodity prices, construction activity and demand for manufactured goods Strong demand for capital equipment products Consistent profit from G
Slide 7: FY21 Financial Highlights
FY21 Financial Highlights 31,295 29,029 29,092 24,250 21,540 Revenue up 8% to $31.3m vs FY20 Statutory NPAT up 64% to $5.1m vs FY20 Adjusted PBT up 41% to $5.9m vs FY20 $4.5m positive operating cashflow FY17 FY18 FY19 FY20 FY21 Revenue ($'000) Fully franked dividend of 2 cents per share
Slide 8: Full Year Results - Overview
Full Year Results - Overview ($m) 2021 2020 Change 2019 2018 Sales revenue 31.3 29.1 8% 29.0 24.2 Profit before tax 6.8 4.5 52% 3.2 1.5 Adjusted profit before tax* 5.9 4.2 41% 3.2 1.5 Net profit after tax 5.1 3.1 64% 2.1 1.0 Earnings per share (cents) 3.8 2.3 64% 1.6 0.8 Weighted average no. of shar
Slide 9: Balance Sheet
Balance Sheet ($m) 2021 2020 Change Net cash position of $4.4m up from $2.7m Cash and cash equivalents 5.3 3.6 45% $0.8m debt for Melbourne platinum factory is Trade and other receivables 4.5 3.8 19% now in short-term due to initial three-year period Inventories 12.5 11.2 11% expiring in Novembe
Slide 10: Cash Flow Statements
Cash Flow Statements ($m) 2021 2020 Net cash inflow from operating activities* 4.5 4.2 Net cash (outflow) from investing activities (0.6) (0.8) Net cash inflow/(outflow) from financing activities (2.2) (3.0) Cash at start of period 3.6 3.2 Net increase/(decrease) in cash 1.7 0.4 Cash at end of perio
Slide 11: Consumables
Consumables ($m) FY21 FY20 FY19 Overview for FY21: Sales revenue 9.3 8.9 8.0 Revenue up 5% on FY20 Change in % * 5% 11% 6% NPBT up 14% on FY20 Strong demand from the mining sector, both domestic and NPBT 2.9 2.5 2.2 international Change in % * 14% 18% 35% New customer acquisitions continue
Slide 12: Precious Metals
Precious Metals ($m) FY21 FY20 FY19 Overview for FY21: Sales revenue 14.4 13.2 13.1 Revenue up 9% on FY20 Change in % * 9% 1% 19% NPBT up 81% on FY20 FY21 NPBT includes $363k of COVID-19 wages subsidies NPBT 2.5 1.4 0.9 (FY20: $114k) Change in % * 81% 50% 1564% Platinum labware products ar
Slide 13: Capital Equipment
Capital Equipment ($m) FY21 FY20 FY19 Overview for FY21: Sales revenue 9.6 8.0 9.2 Revenue up 20% on FY20 Change in % * 20% (13%) 29% NPBT up 159% on FY20 FY21 NPBT includes $392k of COVID-19 wages subsidies NPBT 1.5 0.6 0.6 (FY20: $93k) Change in % * 159% (7%) 244% High level of machine s
Slide 14: Growth Strategy for FY22
Continuing our expansion in the Precious Metals Division, with growth in profit expected to continue Growth Strategy Continue with geographical expansion initiatives for FY22 Release two new capital equipment products Continue to pursue M&A opportunities. Our targets are complementary manufa
Slide 15: Corporate Overview
Corporate Overview Dividends Shareholder Wealth EBIT Earnings Per Declared Per Share Price Market Share Capitalisation Share Financial Year $ Cents Cents Cents $ 2015/16 2,318,737 1.2 0.5 18.0 24,088,645 2016/17 982,440 0.6 0.24 17.0 22,750,387 2017/18 1,598,268 0.8 0.3 16.0 22,081,257 2018/19 3,249
Slide 16: Contact Information
Contact Information Tel: (08) 9244 0600 86 Guthrie Street, Osborne Park WA Vance Stazzonelli – CEO vance@xrfscientific.com 16
Slide 17: Disclaimer
Disclaimer No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonableness of this Investor